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Progress in Understanding and Diagnosing Epidermolytic Hyperkeratosis 
Three papers in this issue deal with the fast-moving field of the 
genetics ofEpidermolytic Hyperkeratosis (EH). Since the reports in 
1992 by the three laboratories of Roop, Steinert, and Fuchs that 
point mutations in filaments composed of the suprabasal keratins Kl 
or K 1 0 are associated with EH, the catalog of mutations involved in 
the disease has expanded. In this issue, Steinert's laboratory (Yang et 
ai, p. 17) describes three new mutations in the Kl protein that affect 
highly conserved amino acids in t!le HI or the beginning ~f the lA 
rod domain segments. These regIOns overlap when keratlll mole-
cules assemble into filaments, and known mutations in EH are clus-
tered in the region. Yang et al also show that synthetic peptides 
containing these mutations are less able than "wild type" peptides to 
disrupt normal filaments, indicating that they have a reduced ability 
to interact with keratin molecules in these filaments. Lane's labora-
tory (McLean et ai, p. 24) describes two additional mutations in the 
lA domain ofKl and two in an analogous region ofKI0 and show 
that all four create restriction fragment length polymorphisms use-
ful in locating the mutations. The McLean and Yang papers de-
scribe the first mutations in the lA domain of a basic, or type II 
keratin, in this case K I, and further support the importance of the 
lA domain in assembly of keratin filaments. Roop's laboratory 
(Rothnagel et ai, p. 13) reports the use of the PCR technique using 
primers from the 1A region of K10 to locate a mutation in an 
affected father and the subsequent demonstration of the same muta-
tion in chorionic villi of twins at the fifteenth week of gestation, 
facilitating the first prenatal diagnosis of EH by a direct gene se-
quencing approach. The affected tyrosine residue is invariant in all 
type I keratins sequenced to date, suggesting that it is critical for 
functional integrity of keratins. These papers provide dramatic evi-
dence of the progress in understanding of EH and set the stage for 
further intervention in genetic skin disease. 
What is the Basis for Genetic Instability in Werner's Syndrome? 
Werner's syndrome is thought to be a genetic model for aging and 
also for susceptibility to cancer, because affected patients exhibit 
many clinical features suggestive of premature aging and also have 
an increased risk of cancer. Chromosome instability and a "muta-
tor" phenotype, with increased formation of gene deletions in 
Werner syndrome cells, are thought to be involved, but the under-
lying molecular defect has not been identified. Plasmid "shuttle 
vectors," which have been used to investigate repair of DNA dam-
age in intact human cells, provide a way of examining Werner's 
syndrome cells. These viruses are introduced into the cell, and what 
happens to the viral DNA is a reflection of how the cell handles its 
own DNA. Because faulty ligation of broken DNA is a genetic 
function that could lead to genetic instability in Werner's syn-
drome, Runger et al (p. 45 in this issue) have used a plasmid "host 
cell ligation assay" to study ligation of the ends of broken DNA 
molecules in Werner's syndrome cells using a shuttle vector as an 
indicator. (Earlier, using the same "host cell ligation assay," they 
described related abnormalities of DNA ligation in cells from pa-
tients with the cancer-prone chromosome breakage syndromes 
ataxia telangiectasia, Bloom's syndrome, and Fanconi's anemia.) 
They transfected a linearized plasmid into three normal and three 
Werner's syndrome lymphoblast cells lines and assessed the effi-
ciency of ligation of the cut ends of the linearized DNA in the host 
cells by measuring survival of the plasmid after 3 days. Survival of 
the plasmid requires the ligation of double-strand breaks of the cut 
DNA by enzymes of the host cell. Runger etal found that the sites of 
DNA ligation had a high incidence of mutation, mainly due to an 
increased rate of deletions, whereas the efficiency of ligation was 
unaffected. These investigators think that error-prone DNA liga-
tion, for example during the repair of double strand breaks that 
occur in DNA, could lead to the spontaneous deletions already 
known to occur in Werner's syndrome. These results suggest that 
accurate ligation of DNA may playa pivotal role in maintaining 
genetic stability. 
The Biologic Activity of Retinoids 
Retinoids are known to play an important role in proliferation and 
differentiation of keratinocytes in vitro and in epidermis irl vivo. 
Most studies of retinoids have been performed with a retinol metab-
olite, retinoic acid (RA). In human epidermis as well as in mouse 
embryos, some retinol (ROH) is also converted into 3,4-didehy-
droretinol (ddROH), which may be a precursor of 3,4-didehydro-
retinoic acid (ddRA), a compound that can alter morphology during 
development (a "morphogen"). It is possible that retinol, via differ-
ing tissue-specific conversion to RA and ddRA, may elicit different 
biologic responses in different tissues. In this issue Torma et al (p. 
49) compare the activities ofRA and ddRA on the differentiation of 
human keratinocytes and murine F9 teratocarcinoma cells to inves-
tigate whether these two metabolites of retinol may produce differ-
ent biologic responses in target tissues. They found that RA and 
ddRA are equipotent inducers of differentiation in F9 cells and also 
inhibit keratinization to the same extent both in a reconstructed skin 
model and also in an assay for keratinocyte transglutaminase. Fur-
thermore, RA and ddRA had almost equal affinities for retinoic acid 
receptors. To look for possible differences in the metabolism of the 
two retinoids, the authors analyzed cells and media by HPLC after 
24 hours of incubation. They were surprised to find that although 
both were equipotent, the concentration of retinoids in keratino-
cytes was 25 -130 times higher after exposure of the cells to RA 
than to ddRA, indicating that ddRA was metabolized much more 
rapidly. Considering that under physiologic conditions some types 
of epithelial cells produce both RA and ddRA, these results suggest 
the possibility that the regulation of gene expression by vitamin A 
depends not only on the retinoic acid receptors but also on the tissue 
specific production and possibly also on the metabolism of these two 
retinoids. 
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What is the Natural Role of the 230-kD Pemphigoid Antigen? 
There has been great progress in the understanding of the structure 
of the antigens recognized by autoantibodies in patients with pem-
phigoid in the last few years, some of which have been reported in 
theJoumal. There are two major proteins recognized by the autoan-
tibodies; a 230-kD protein component of the hemidesmosomal 
plaque (BP230, or BPAG1) and a 180-kD transmembrane protein 
(BP180, also called BPAG2 or type XVII collagen). Sequence anal-
ysis of BP230 is consistent with location of the protein in the cyto-
plasm rather than in the cell membrane or on the cell surface and 
shows that it belongs to a family of intracellular "intermediate fila-
ment associated proteins" (nicknamed IFAPs) that includes plectin 
and the desmosomal plaque component desmoplakin. For this rea-
son and also because BP230 has been found by electron microscopy 
in the region of the hemidesmosomal plaque with which keratin 
filaments associate, BP230 is a candidate for a linking protein, i.e., a 
protein that links keratin filaments, which are widely dispersed in 
the cytoplasm, to the hemidesmosomal plaque at the basal aspect of 
the cell. In this issue (p. 39), Klatte and Jones describe a method for 
purifying BP230. Images of individual BP230 molecules visualized 
by an electron microscopic technique, rotary shadowing, are con-
sistent with the predicted secondary structure ofBP230 obtained by 
analyzing cDNA clones. BP230 is the first BP antigen and also the 
first hemidesmosomal plaque component to be isolated. With puri-
fied BP230 at hand it will now be possible to study its interactions 
with other proteins such as keratins, which are easily purified in 
large quantities, and later with other cytoskeletal and hemidesmo-
somal plaque proteins. 
Superantigens and the Immune Response in the Skin 
The family of toxins produced by StaphylococCIIs aureus and other 
bacteria, such as staphylococcal enterotoxins, exfoliative toxin, 
toxic shock syndrome toxin-1, pyrogenic exotoxins, and myco-
plasma arthriditis mitogen, are called "superantigens" because they 
have the ability; when presented to T cells by appropriate major 
histocompatibility class II+ accessory cells, to activate essentially all 
T cells bearing T-cell antigen receptors with particular Vp gene 
segments. Thus many more T cells respond to superantigens than to 
conventional antigens. The possible participation of superantigens 
in skin disease is a hot topic in dermatology, and the problem of 
what criteria are necessary to show that a human skin disease in-
volves a response to superantigens was discussed in a commentary in 
the October 1993 issue of the Journal. Because it is at the interface 
between host and environment, the skin is likely to be responsive to 
stimulation by superantigens. Superantigenic exotoxi1l5 are asso-
ciated with skin disorders as well as with systemic diseases with 
cutaneous manifestati01l5, including staphylococcal scalded skin 
syndrome, toxic shock syndrome, and group A streptococcal infec-
tions. The common association of skin disorders with superantigen-
containing bacteria, however, as well as the apparent ability ofbac-
terial infection to trigger flares in some skin disorders (e.g., 
streptococcal disease and psoriasis), have led to speculation that 
these bacterial toxins may be able to modify the immune response. 
In this issue Tokura et al (p. 31) show that not only Langerhans cells 
but also class II - bearing keratinocytes can function as accessory 
cells in the T-cell response to bacterial superantigens. They also 
observed that superantigenic toxins stimulate keratinocytes to pro-
duce cytokines with the ability to activate T cells. These findings 
suggest that modulation of the immune resp01l5e by superantige1l5 
may well occur in the skin. These studies add to the growing evi-
dence, as yet circumstantial, that superantigens may well be in-
volved in skin disease. 
